CBIO - Catalyst Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue61,0183991,750
Cost of Revenue21,47412,84710,5555,958
Gross Profit-21,468-11,829-10,156-4,208
Operating Expenses
Research Development----
Selling General and Administrative12,2549,9939,2629,594
Non Recurring----
Total Operating Expenses33,72822,84019,81715,552
Operating Income or Loss-33,722-21,822-19,418-13,802
Income from Continuing Operations
Total Other Income/Expenses Net3,6672612,473-960
Earnings Before Interest and Taxes-33,722-21,822-19,418-13,802
Interest Expense----1,478
Income Before Tax-30,055-21,561-16,945-14,762
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-30,055-21,561-16,945-14,762
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-30,055-21,561-16,945-14,762
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-30,055-25,512-16,945-14,762